Increasing the Safety of Biological Liquid Waste Disposal
INTEGRA has launched new single-use waste collection bottles for its VACUSIP benchtop aspiration system – a compact, portable solution for safe and convenient disposal of small volumes of biological liquid waste.
The introduction of new disposable bottles allows VACUSIP users to go one step further in terms of operational safety and reducing the cost of handling/disposal of biohazardous substances. Made of heavy duty polypropylene, the new single-use collection bottle is shatterproof and vacuum resistant, eliminating risks of breakage and contamination by the biological agents during manipulation.
Benefiting from a compact design enables all manipulation, aspiration and liquid waste collection steps using a VACUSIP to be done inside a biosafety cabinet, reducing risks of human and environmental contamination by manipulated biohazard agents. A wide range of adapters are available enabling easy aspiration of liquid from almost any labware including small centrifuges tubes, microplates or flasks. When full, the collection bottle is simply disconnected from the VACUSIP system and securely sealed with the supplied lid.
After decontamination of the bottle surface, the liquid waste can be simply and safely transferred to a licensed company for correct destruction of the biohazardous substances. Using the new VACUSIP single-use waste collection bottles therefore not only reduces biohazard handling risks but also eliminates the need, and considerable cost, of maintaining an in-house waste disposal facility.
Related News
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance